February 2018

Quantitative proteomic analysis of Isorhamnetin treatment in human liver cancer cells

Isorhamnetin (Iso) exhibits antitumor effects in promyelotic leukemia and lung cancers. However, its effect in liver cancer is not clear. This study explored the effects of Iso in human liver cancer cells and profiled the differential proteins upon Iso treatment, which contributes to a better understanding of its anticancer mechanisms. Stable isotope labeling with amino acids in cell culture-mass spectrometry:...

Author(s): Runhuan Fei and Haiyan Wei